William Heyburn Sells 31,671 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Strata Critical Medical (NASDAQ:SRTA) CEO William Heyburn sold 31,671 shares of Strata Critical Medical stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $185,908.77. Following the sale, the chief executive officer directly owned 1,548,997 shares of the company’s stock, valued at $9,092,612.39. The trade was a 2.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Stock Down 2.1%

Shares of SRTA stock traded down $0.12 during midday trading on Wednesday, hitting $5.49. 1,306,162 shares of the company were exchanged, compared to its average volume of 874,584. The stock has a market cap of $475.05 million, a price-to-earnings ratio of -68.63 and a beta of 2.20. The firm has a 50 day moving average price of $5.14. Strata Critical Medical has a 52 week low of $3.57 and a 52 week high of $6.50.

Strata Critical Medical (NASDAQ:SRTA) last announced its earnings results on Wednesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.07. The business had revenue of $67.38 million during the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. As a group, equities research analysts predict that Strata Critical Medical will post -0.14 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on SRTA shares. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. B. Riley Financial started coverage on shares of Strata Critical Medical in a report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective for the company. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. Finally, Craig Hallum started coverage on shares of Strata Critical Medical in a report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Strata Critical Medical currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.00.

Hedge Funds Weigh In On Strata Critical Medical

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Bank of America Corp DE raised its position in shares of Strata Critical Medical by 16.2% in the 1st quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after buying an additional 25,379 shares in the last quarter. Quantinno Capital Management LP raised its position in shares of Strata Critical Medical by 98.7% in the 1st quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock valued at $599,000 after buying an additional 71,155 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Strata Critical Medical by 11.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after purchasing an additional 172,154 shares in the last quarter. Principal Financial Group Inc. acquired a new position in Strata Critical Medical during the 1st quarter worth approximately $537,000. Finally, Granite Investment Partners LLC increased its position in Strata Critical Medical by 77.0% during the 1st quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after purchasing an additional 7,911 shares in the last quarter. 47.36% of the stock is currently owned by institutional investors and hedge funds.

Strata Critical Medical Company Profile

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.